Cargando…
Intrathecal Administration of Nusinersen Using the Ommaya Reservoir in an Adult with 5q-Related Spinal Muscular Atrophy Type 1 and Severe Spinal Deformity
Spinal muscular atrophy (SMA) is a hereditary neuromuscular disorder, typically caused by survival motor neuron 1 (SMN1) gene deletion in chromosome 5q resulting in loss of SMN protein. SMA type 1 progresses rapidly leading to increased mortality usually before the age of 2 years. Nusinersen, the fi...
Autores principales: | Papaliagkas, Vasileios, Foroglou, Nikolaos, Toulios, Petros, Moschou, Maria, Gavriilaki, Maria, Notas, Konstantinos, Chatzikyriakou, Evangelia, Zafeiridou, Georgia, Arnaoutoglou, Marianthi, Kimiskidis, Vasilios K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647073/ https://www.ncbi.nlm.nih.gov/pubmed/34950009 http://dx.doi.org/10.1159/000519831 |
Ejemplares similares
-
COVID-19 pandemic impact on neurologic emergencies: a single-center retrospective cohort study
por: Gavriilaki, Maria, et al.
Publicado: (2022) -
Cognitive Impairment in MRI-Negative Epilepsy: Relationship between Neurophysiological and Neuropsychological Measures
por: Papaliagkas, Vasileios, et al.
Publicado: (2023) -
Intrathecal nusinersen administration in adult spinal muscular
atrophy patients with complex spinal anatomy
por: Cordts, Isabell, et al.
Publicado: (2020) -
Intrathecal administration of nusinersen for spinal muscular atrophy: report of three cases with severe spinal deformity
por: Nakao, Sayo, et al.
Publicado: (2020) -
Intrathecal Injections in Children With Spinal Muscular Atrophy: Nusinersen Clinical Trial Experience
por: Haché, Manon, et al.
Publicado: (2016)